To test Lzts1 role in taxanes resistance in breast cancer, we investigate Lzts1 deregulation impact on taxanes sensitivity in four breast cancer cell lines (MCF7, MDA-MB-231, MDA-MB-436, and T-47D). Here, LZTS1 is linked to breast carcinoma.